Glaxo (GSK) and Theravance (THRX) Announce Positive Results from Phase 2b Study for LABA, '444
Tweet Send to a Friend
GlaxoSmithKline Plc (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from the phase 2b study of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
